These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6861961)

  • 1. Altered hyperemic response of the coronary arterial bed in alloxan-diabetes.
    Koltai MZ; Wagner M; Pogátsa G
    Experientia; 1983 Jul; 39(7):738-40. PubMed ID: 6861961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vascular responses to hypoxia in the diabetic lamb: independence from adenosine and autonomic mechanisms.
    Downing SE; Lee JC; Werner JC
    Am Heart J; 1986 Aug; 112(2):272-9. PubMed ID: 3017081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sympathetic stimulation and adenosine on coronary circulation and heart function in diabetes mellitus.
    Koltai MZ; Jermendy G; Kiss V; Wagner M; Pogátsa G
    Acta Physiol Hung; 1984; 63(2):119-25. PubMed ID: 6741561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and altered diabetic vasoregulation.
    Koltai MZ; Hadhazy P; Köszeghy A; Ballagi-Pordany G; Pogatsa G
    Biomed Biochim Acta; 1988; 47(9):849-54. PubMed ID: 3248123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered adrenergic responses of the coronary arterial bed in alloxan-diabetic dogs.
    Palik I; Koltai MZ; Wagner M; Kolonics I; Pogátsa G
    Experientia; 1982 Aug; 38(8):934-5. PubMed ID: 7128730
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of vascular adrenergic mechanisms in the haemodynamic and PGI2 stimulating effects of angiotensin in diabetic dogs.
    Koltai MZ; Pósa I; Kocsis E; Rösen P; Pogátsa G
    Mol Cell Biochem; 1996; 163-164():151-7. PubMed ID: 8974051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries.
    Koltai MZ; Rösen P; Hadházy P; Ballagi-Pordány G; Köszeghy A; Pogátsa G
    Diabetologia; 1988 Sep; 31(9):681-6. PubMed ID: 2853089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes.
    Zhao G; Zhang X; Smith CJ; Xu X; Ochoa M; Greenhouse D; Vogel T; Curran C; Hintze TH
    Am J Physiol; 1999 Jul; 277(1):H268-78. PubMed ID: 10409206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus.
    Setty S; Sun W; Martinez R; Downey HF; Tune JD
    J Appl Physiol (1985); 2004 Jul; 97(1):431-8. PubMed ID: 14978008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-dependent K(+) channels contribute to local metabolic coronary vasodilation in experimental diabetes.
    Tune JD; Yeh C; Setty S; Downey HF
    Diabetes; 2002 Apr; 51(4):1201-7. PubMed ID: 11916945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased vasoconstrictor response to noradrenaline in femoral vascular bed of diabetic dogs. Is thromboxane A2 involved?
    Koltai MZ; Rösen P; Ballagi-Pordány G; Hadházy P; Pogátsa G
    Cardiovasc Res; 1990 Sep; 24(9):707-10. PubMed ID: 2121358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin induced reversibility of altered responsiveness in femoral arterial bed of diabetic dogs.
    Pogátsa G; Koltai MZ; Hadházy P; Köszeghy A; Ballagi-Pordány G
    Diabetes Res; 1988 Sep; 9(1):41-5. PubMed ID: 3071444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of coronary dilator action of adenosine in experimental diabetes.
    Downing SE
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H102-7. PubMed ID: 3893160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic- vs. ischemia-induced coronary artery vasodilation.
    Warltier DC; Gross GJ; Brooks HL
    Am J Physiol; 1981 May; 240(5):H767-74. PubMed ID: 7235035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased flow reserve in "stunned" myocardium after a 10-min coronary occlusion.
    Triana JF; Bolli R
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H793-804. PubMed ID: 1887925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on prostaglandins F2 alpha, I2, and indomethacin on isolated coronary arteries from healthy and alloxan-diabetic dogs.
    Palik I; Hadházy P; Magyar K; Malomvölgyi B; Wagner M; Pogátsa G
    Experientia; 1981; 37(8):863-4. PubMed ID: 7026273
    [No Abstract]   [Full Text] [Related]  

  • 17. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes.
    Ammar RF; Gutterman DD; Brooks LA; Dellsperger KC
    Cardiovasc Res; 2000 Aug; 47(3):595-601. PubMed ID: 10963732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of coronary endothelial dysfunction in experimental diabetes.
    Koltai MZ; Hadházy P; Pósa I; Kocsis E; Winkler G; Rösen P; Pogátsa G
    Cardiovasc Res; 1997 Apr; 34(1):157-63. PubMed ID: 9217885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
    Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
    Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished vasodilation; imbalance of synthesized cyclooxygenase products by adrenergic mediation in diabetic coronaries of the dog.
    Koltai MZ; Rösen P; Pogátsa G
    Prog Clin Biol Res; 1989; 301():449-53. PubMed ID: 2508113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.